+96.6%
CURE vs SPY
+14.6%
+82.0%
-31.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SPY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +9.1% | +1.7% | +7.5% | +7.9% |
| 7D | +17.1% | -0.7% | +17.9% | +17.6% |
| 30D | +42.6% | -1.0% | +43.6% | +43.4% |
| 3M | +54.1% | -0.3% | +54.5% | +54.1% |
| 6M | +109.0% | +7.3% | +101.7% | +90.1% |
| YTD | +63.4% | +13.3% | +50.1% | +34.5% |
| 1Y | +96.6% | +14.8% | +81.8% | +59.3% |
| All | +96.6% | +14.6% | +82.0% | +59.3% |
Cumulative growth
Daily Returns
Daily percentage return beside SPY.
Daily Out/Under-Performance
Portfolio return minus SPY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SPY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling